Type II Variation [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-09-17 18:36 (4662 d 14:21 ago) – Posting: # 11508
Views: 6,522

Hi Elena,

❝ If the biobatch is < 100,000 units, is scale-up allowed according to EU regulations?


Do I get you right – you got the approval with a production batch which is <100,000 units and want to scale up? IMHO, this is a “Major Variation of Type II” as defined in 1234/2008/EC Article 2(3), which

[…] means a variation which is not an extension and which may have a significant impact on the quality, safety or efficacy of the medicinal product concerned.

If waiving criteria of the GL are not fulfilled, I would say you need another BE study.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
132 visitors (0 registered, 132 guests [including 13 identified bots]).
Forum time: 08:58 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5